This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
VSS Capital Partners (VSS), a private investment firm investing in the healthcare, education, and business services industries, has made a growth capitalinvestment in Lane Four Consulting (Lane Four), a consulting partner for companies using Salesforce to scale operations.
The Business Services Fund , led by Partners Brad Morehead , Rory Kenny , Matt Sweeney , and Mickey Jiang , invests in lower middle market companies with $5 million to $50 million of revenue and $1 million to $7 million of EBITDA. It acquired its first two businesses with the buys of Rozel Electrical Safety Consultants and BCH Safety.
ToxStrategies , a portfolio company of Renovus Capital Partners that provides scientific consultingservices, has acquired Suttons Creek. Suttons Creek provides pharmaceutical companies with consultingservices—conceptualization, device engineering, and quality assurance—for developing drug and medical device combinations.
These businesses should, ideally, be churning out lots of free cash flow (what's left of cash flow after capitalinvestments) so they don't need to rely on banks to finance growth. billion per year from the consultancy firm. a year earlier, giving the professionalservices company an annualized dividend of $5.16
Nonoperating results for the quarter included $108 million of net investment gains, driven primarily by gains linked to a minority investment and unhedged seed capitalinvestments. G&A expense was up 8% year over year, primarily due to the timing of technology spend last year and higher professionalservices expense.
million in adjusted free cash flow in 2024, slightly below our guidance of approximately $110 million, primarily due to increased capitalinvestments required by 2025's anticipated revenue growth. Finally, we're proud to announce our Agentic AI consulting practice. We also delivered $107.4 million in revenue.
Nonoperating results for the quarter included 113 million of net investment gains, driven primarily by noncash mark-to-market gains on our unhedged seed capitalinvestments and minority investments. Operating income of 1.9 billion and earnings per share of $10.36 were each up 12% year over year.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content